Evidence map›Paper›PMID 35903747›Full record

ArticleFrontiers in psychology2022

Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer.

Eileen H Shinn, Brooke E Busch, Neda Jasemi, Cole A Lyman, J Tory Toole, Spencer C Richman, William Fraser Symmans, Mariana Chavez-MacGregor, Susan K Peterson, Gordon Broderick

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Eileen H ShinnDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Brooke E BuschDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Neda JasemiDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Cole A LymanCenter for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, United States.
J Tory TooleCenter for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, United States.
Spencer C RichmanCenter for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, United States.
William Fraser SymmansDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Mariana Chavez-MacGregorDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Susan K PetersonDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Gordon BroderickCenter for Clinical Systems Biology, Rochester General Hospital, Rochester, NY, United States.
The University of Texas MD Anderson Cancer Center · USRochester General Hospital · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Early patient discontinuation from adjuvant endocrine treatment (ET) is multifactorial and complex: Patients must adapt to various challenges and make the best decisions they can within changing contexts over time. Predictive models are needed that can account for the changing influence of multiple factors over time as well as decisional uncertainty due to incomplete data. AtlasTi8 analyses of longitudinal interview data from 82 estrogen receptor-positive (ER+) breast cancer patients generated a model conceptualizing patient-, patient-provider relationship, and treatment-related influences on early discontinuation. Prospective self-report data from validated psychometric measures were discretized and constrained into a decisional logic network to refine and validate the conceptual model. Minimal intervention set (MIS) optimization identified parsimonious intervention strategies that reversed discontinuation paths back to adherence. Logic network simulation produced 96 candidate decisional models which accounted for 75% of the coordinated changes in the 16 network nodes over time. Collectively the models supported 15 persistent end-states, all discontinued. The 15 end-states were characterized by median levels of general anxiety and low levels of perceived recurrence risk, quality of life (QoL) and ET side effects. MIS optimization identified 3 effective interventions: reducing general anxiety, reinforcing pill-taking routines, and increasing trust in healthcare providers. Increasing health literacy also improved adherence for patients without a college degree. Given complex regulatory networks' intractability to end-state identification, the predictive models performed reasonably well in identifying specific discontinuation profiles and potentially effective interventions.

Indexed as

adherencebehavioral feedback networkcomputational modelingforecast predictionhormone receptor-positive breast cancerrescue strategy

Identifiers

PMID35903747
PMCPMC9315289
OpenAlexW4285042285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.